JB Pritzker Says He Used GLP-1s to Lose 80 Pounds
Gov. JB Pritzker of Illinois, widely seen as a potential presidential candidate, revealed in an interview on “CBS Mornings” that he had been on a GLP-1 regimen since 2024.
Governor JB Pritzker's disclosure about using GLP-1s, a class of medications often prescribed for type 2 diabetes and obesity, to lose 80 pounds is significant not only because of his high profile but also due to the growing interest in these medications. GLP-1 receptor agonists, such as semaglutide and tirzepatide, have gained popularity for their effectiveness in aiding weight loss, with some formulations approved for obesity treatment.
This revelation comes at a time when the conversation around obesity and weight loss treatments is increasingly prominent. The use of GLP-1s by individuals beyond those with diabetes, including for cosmetic weight loss, has sparked debate among health professionals and the public. Pritzker's experience, shared on a major news platform, may further amplify public discussion and scrutiny of these medications, especially given his potential run for higher office.
As the public and media continue to focus on health and wellness, particularly in the context of political figures, it's essential to monitor how this conversation evolves. Key areas to watch include any regulatory changes or updates on the use of GLP-1s, further disclosures from public figures about their health and wellness practices, and how these discussions influence public perception and policy debates around healthcare and obesity treatment.
Originally reported by nytimes.com. MyNews adds analysis for general news readers.